Response to: 'Correspondence on 'Cardiovascular effects of biological versus conventional synthetic disease-modifying antirheumatic drug therapy in treatment-naive, early rheumatoid arthritis'' by Georgiadis <i>et al</i>.

Plein, Sven; Buch, Maya H

Response to: 'Correspondence on 'Cardiovascular effects of biological versus conventional synthetic disease-modifying antirheumatic drug therapy in treatment-naive, early rheumatoid arthritis'' by Georgiadis et al.

Plein, Sven; Buch, Maya H.

Afiliación

Plein S; Multidisciplinary Cardiovascular Research Centre (MCRC) & Leeds Institute of Cardiovascular and Metabolic Medicine, University of Leeds, Leeds, UK.
Buch MH; Leeds Institute of Rheumatic and Musculoskeletal Medicine, University of Leeds, Leeds, UK maya.buch@manchester.ac.uk.

Ann Rheum Dis ; 82(4): e90, 2023 04.

Article en En | MEDLINE | ID: mdl-33558258

Asunto(s)

Antirreumáticos; Artritis Reumatoide; Productos Biológicos; Humanos; Antirreumáticos/uso terapéutico; Artritis Reumatoide/tratamiento farmacológico; Etanercept/uso terapéutico; Resultado del Tratamiento; Quimioterapia Combinada; Productos Biológicos/uso terapéutico

Palabras clave

arthritis; atherosclerosis; cardiovascular diseases; etanercept; magnetic resonance imaging; rheumatoid

Texto completo

Imprimir

XML

PubMed Links

Buscar en Google

Texto completo: 1 Base de datos: MEDLINE Asunto principal: Artritis Reumatoide / Productos Biológicos / Antirreumáticos Idioma: En Revista: Ann Rheum Dis Año: 2023 Tipo del documento: Article

Texto completo

Imprimir

XML

PubMed Links

Buscar en Google